Global Lipid Nanoparticle CDMO Market Growth (Status and Outlook) 2025-2031
Description
The global Lipid Nanoparticle CDMO market size is predicted to grow from US$ 6999 million in 2025 to US$ 13780 million in 2031; it is expected to grow at a CAGR of 12.0% from 2025 to 2031.
A Contract Development and Manufacturing Organization (CDMO) that specializes in the development and production of lipid nanoparticles (LNPs). LNPs are used in various biomedical applications, particularly for drug delivery systems, including RNA-based therapies like mRNA vaccines. A lipid nanoparticle CDMO provides services ranging from the formulation of lipid nanoparticles to large-scale production, ensuring quality, scalability, and compliance with regulatory standards.
United States market for Lipid Nanoparticle CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Lipid Nanoparticle CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Lipid Nanoparticle CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Lipid Nanoparticle CDMO players cover GenScript, Creative Biolabs, Merck, Cytiva, WuXi STA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Lipid Nanoparticle CDMO Industry Forecast” looks at past sales and reviews total world Lipid Nanoparticle CDMO sales in 2024, providing a comprehensive analysis by region and market sector of projected Lipid Nanoparticle CDMO sales for 2025 through 2031. With Lipid Nanoparticle CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lipid Nanoparticle CDMO industry.
This Insight Report provides a comprehensive analysis of the global Lipid Nanoparticle CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Lipid Nanoparticle CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lipid Nanoparticle CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lipid Nanoparticle CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lipid Nanoparticle CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Lipid Nanoparticle CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
Solid Lipid Nanoparticles
Nanostructured Lipid Carriers
Cationic Lipid-Nucleic Acid Complexes
Segmentation by Application:
Gene Therapy
Vaccine Development
Cancer Treatment
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GenScript
Creative Biolabs
Merck
Cytiva
WuXi STA
Carcell
Croda International
Detai Biotechnology
Waters
MicroNano Biologics
Precigenome
Evonik
Avanti Polar Lipids
Genevant Sciences
Nippon Fine Chemical
Lipoid
Please note: The report will take approximately 2 business days to prepare and deliver.
A Contract Development and Manufacturing Organization (CDMO) that specializes in the development and production of lipid nanoparticles (LNPs). LNPs are used in various biomedical applications, particularly for drug delivery systems, including RNA-based therapies like mRNA vaccines. A lipid nanoparticle CDMO provides services ranging from the formulation of lipid nanoparticles to large-scale production, ensuring quality, scalability, and compliance with regulatory standards.
United States market for Lipid Nanoparticle CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Lipid Nanoparticle CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Lipid Nanoparticle CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Lipid Nanoparticle CDMO players cover GenScript, Creative Biolabs, Merck, Cytiva, WuXi STA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Lipid Nanoparticle CDMO Industry Forecast” looks at past sales and reviews total world Lipid Nanoparticle CDMO sales in 2024, providing a comprehensive analysis by region and market sector of projected Lipid Nanoparticle CDMO sales for 2025 through 2031. With Lipid Nanoparticle CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lipid Nanoparticle CDMO industry.
This Insight Report provides a comprehensive analysis of the global Lipid Nanoparticle CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Lipid Nanoparticle CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lipid Nanoparticle CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lipid Nanoparticle CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lipid Nanoparticle CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Lipid Nanoparticle CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
Solid Lipid Nanoparticles
Nanostructured Lipid Carriers
Cationic Lipid-Nucleic Acid Complexes
Segmentation by Application:
Gene Therapy
Vaccine Development
Cancer Treatment
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GenScript
Creative Biolabs
Merck
Cytiva
WuXi STA
Carcell
Croda International
Detai Biotechnology
Waters
MicroNano Biologics
Precigenome
Evonik
Avanti Polar Lipids
Genevant Sciences
Nippon Fine Chemical
Lipoid
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
135 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Lipid Nanoparticle CDMO Market Size by Player
- 4 Lipid Nanoparticle CDMO by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Lipid Nanoparticle CDMO Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
